Product Information
Tafamidis meglumine is a drug that belongs to the class of drugs for treating cardiomyopathy. It is a prodrug of tafamidis which is hydrolyzed in vivo to its active form, tafamidis meglumine. Tafamidis meglumine has long-term efficacy and prevents the progression of heart failure by inhibiting the development of cardiac hypertrophy. This drug also has been shown to be effective against brain natriuretic peptides and other symptoms such as edema, anemia, and renal dysfunction. Tafamidis meglumine inhibits the activity of protein phosphatase 2A (PP2A), which dephosphorylates cardiac troponin I at serine residue 222. This leads to increased levels of troponin I, which induces apoptosis in cardiomyocytes.
Chemical properties
Technical inquiry about: 3D-FT159381 Tafamidis meglumine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
